A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06328439 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06328439
- Sponsor
- Avistone Biotechnology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-19
- Primary completion
- 2027-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.